Clinical Trial Update: T-Cell Mitochondrial Respiration Response to Ketone Monoester Supplement in Healthy Volunteers and COVID-19

View source ↗

Summary

A clinical trial studying T-cell mitochondrial respiration in response to a ketone monoester supplement in healthy volunteers and COVID-19 was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Ketone monoester supplement (ketone monoester)

Snippet

Sponsor: Duke University | Conditions: COVID-19 Acute Respiratory Distress Syndrome | Status: WITHDRAWN